A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/mds.29450
PubMed Identifier: 37246815
Publication URI: http://europepmc.org/abstract/MED/37246815
Type: Journal Article/Review
Volume: 38
Parent Publication: Movement disorders : official journal of the Movement Disorder Society
Issue: 8
ISSN: 0885-3185